Form 8-K - Current report:
SEC Accession No. 0001558370-23-003498
Filing Date
2023-03-10
Accepted
2023-03-10 17:06:21
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20230310x8k.htm   iXBRL 8-K 37445
  Complete submission text file 0001558370-23-003498.txt   154534

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20230310.xsd EX-101.SCH 3375
3 EX-101.LAB glyc-20230310_lab.xml EX-101.LAB 15361
4 EX-101.PRE glyc-20230310_pre.xml EX-101.PRE 10380
6 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20230310x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 23724606
SIC: 2834 Pharmaceutical Preparations